|

mRNA-2808 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • ModernaTX, Inc.1

Indications

  • Relapsed or Refractory Multiple Myeloma1
  • Cancer1

Birmingham, Alabama1 trial

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

University of Alabama at Birmingham Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.